Harman Patil

AVN 101

Updated on
Share on FacebookTweet on TwitterShare on LinkedIn
ChemSpider  24643855
Formula  C21H24N2
3D model (Jmol)  Interactive image
Molar mass  304.44 gĀ·mol

AVN-101, a close structural analogue of latrepirdine, is a selective 5-HT6 receptor antagonist which is under development by Avineuro Pharmaceuticals for the treatment of Alzheimer's disease and anxiety disorders. As of November 2013, it is in phase II clinical trials for these indications.


AVN-101 Wikipedia

Similar Topics
The Death of the Incredible Hulk
Jihad Ballout
Bob Murray (Australian footballer)